Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing […]
Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based retention equity grant” to MacMillan after he had begun […]
Tissue Regenix closes $30m CellRight acquisition
Tissue Regenix (LON:TRX) said today it closed its $30 million (£23 million) acquisition of CellRight Technologies and its line of spinal surgery and orthopedic products. Leeds, England-based Tissue Regenix said it expects that the acquisition will increase its US sales by more than double while expanding the company’s presence in the US healthcare market. Tissue Regenix’s technology is […]
Tissue Regenix slides after $30m buyout of CellRight Technologies
Tissue Regenix (LON:TRX) shares came under pressure today after the regenerative medicine company said it paid $30 million (£23 million) to acquire CellRight Technologies and its line of spine surgery and orthopedics products. Leeds, U.K.-based Tissue Regenix said it funded the deal with a $52 million (£40 million) flotation of 400 million shares. CellRight is based in San Antonio, […]
Tissue Regenix expands, launches DermaPure in US
Tissue Regenix said today it expanded its operations to the US, now offering its DermaPure product for chronic and acute wound care indications in the region. The U.K.-based company’s dCell decellularization technology is a multi-tissue regenerative medical platform designed for use in a number of applications to allow the body to regenerate critical tissue through […]
Tissue Regenix CE Mark expected 6 months early
Tissue Regenix said today it expects to pick up CE Mark approval in the European Union for its OrthoPure XT and XM procine tendon and meniscus products approximately 6 months ahead of schedule. Clinical trials are currently underway for both products, the company said, and positive clinical data from the trials has resulted in an […]
Uroplasty’s new CFO hails from Synovis | Personnel Moves
Sirona Dental CFO steps down after 15 years | Personnel Moves
Sirona Dental (NSDQ:SIRO) CFO Simone Blank is slated in October to hand over her title to new-comer Ulrich Michel, who formerly worked as a finance chief in the commercial auto and heating/ventilation industries.
Blank worked for Sirona for 15 years, taking on the CFO title in 2005. The company did not state a reason for her departure, but she will stay on until October 14 to help smooth the transition.
